메뉴 건너뛰기




Volumn 8, Issue 7, 2013, Pages

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis

(15)  Price, Huw a   Dunn, David b   Pillay, Deenan a   Bani Sadr, Firouze c   de Vries Sluijs, Theodora d   Jain, Mamta K e   Kuzushita, Noriyoshi f   Mauss, Stefan g   Núñez, Marina h   Nüesch, Reto i   Peters, Marion j   Reiberger, Thomas k   Stephan, Christoph l   Tan, Lionel m   Gilson, Richard a  


Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; LAMIVUDINE; TENOFOVIR;

EID: 84880016598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068152     Document Type: Article
Times cited : (72)

References (46)
  • 1
    • 85062055676 scopus 로고    scopus 로고
    • Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study
    • Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, et al. (2006) Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 166: 1632-1641.
    • (2006) Arch Intern Med , vol.166 , pp. 1632-1641
    • Weber, R.1    Sabin, C.A.2    Friis-Moller, N.3    Reiss, P.4    El-Sadr, W.M.5
  • 2
    • 72449166927 scopus 로고    scopus 로고
    • British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010
    • Brook G, Main J, Nelson M, Bhagani S, Wilkins E, et al. (2010) British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010. HIV Med 11: 1-30.
    • (2010) HIV Med , vol.11 , pp. 1-30
    • Brook, G.1    Main, J.2    Nelson, M.3    Bhagani, S.4    Wilkins, E.5
  • 3
    • 77957331059 scopus 로고    scopus 로고
    • Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses
    • Woo G, Tomlinson G, Nishikawa Y, Kowgier M, Sherman M, et al. (2010) Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology 139: 1218-1229.
    • (2010) Gastroenterology , vol.139 , pp. 1218-1229
    • Woo, G.1    Tomlinson, G.2    Nishikawa, Y.3    Kowgier, M.4    Sherman, M.5
  • 4
    • 68049122102 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
    • (2009) PLoS Med , vol.6
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4
  • 5
    • 77957358835 scopus 로고    scopus 로고
    • Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand
    • Avihingsanon A, Lewin SR, Kerr S, Chang JJ, Piyawat K, et al. (2010) Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand. Antivir Ther 15: 917-922.
    • (2010) Antivir Ther , vol.15 , pp. 917-922
    • Avihingsanon, A.1    Lewin, S.R.2    Kerr, S.3    Chang, J.J.4    Piyawat, K.5
  • 6
    • 4744348324 scopus 로고    scopus 로고
    • Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus
    • Bani-Sadr F, Palmer P, Scieux C, Molina JM, (2004) Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus. Clin Infect Dis 39: 1062-1064.
    • (2004) Clin Infect Dis , vol.39 , pp. 1062-1064
    • Bani-Sadr, F.1    Palmer, P.2    Scieux, C.3    Molina, J.M.4
  • 7
    • 33646188544 scopus 로고    scopus 로고
    • Tenofovir for chronic hepatitis B virus infection in HIV-coinfected patients
    • Butt AA, (2006) Tenofovir for chronic hepatitis B virus infection in HIV-coinfected patients. AIDS Reader 16: 219-222.
    • (2006) AIDS Reader , vol.16 , pp. 219-222
    • Butt, A.A.1
  • 8
    • 78649711070 scopus 로고    scopus 로고
    • Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus
    • de Vries-Sluijs TE, Reijnders JG, Hansen BE, Zaaijer HL, Prins JM, et al. (2010) Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus. Gastroenterology 139: 1934-1941.
    • (2010) Gastroenterology , vol.139 , pp. 1934-1941
    • de Vries-Sluijs, T.E.1    Reijnders, J.G.2    Hansen, B.E.3    Zaaijer, H.L.4    Prins, J.M.5
  • 9
    • 1842607685 scopus 로고    scopus 로고
    • Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus
    • Dore GJ, Cooper DA, Pozniak AL, DeJesus E, Zhong L, et al. (2004) Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and-experienced patients coinfected with HIV-1 and hepatitis B virus. J Infect Dis 189: 1185-1192.
    • (2004) J Infect Dis , vol.189 , pp. 1185-1192
    • Dore, G.J.1    Cooper, D.A.2    Pozniak, A.L.3    DeJesus, E.4    Zhong, L.5
  • 10
    • 84867034225 scopus 로고    scopus 로고
    • Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients
    • Engell CA, Pham VP, Holzman RS, Aberg JA, (2011) Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients. ISRN Gastroenterol 2011: 405390.
    • (2011) ISRN Gastroenterol , vol.2011 , pp. 405390
    • Engell, C.A.1    Pham, V.P.2    Holzman, R.S.3    Aberg, J.A.4
  • 11
    • 39349102009 scopus 로고    scopus 로고
    • Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine
    • Gutierrez S, Guillemi S, Jahnke N, Montessori V, Harrigan PR, et al. (2008) Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine. Clin Infect Dis 46: e28-30.
    • (2008) Clin Infect Dis , vol.46
    • Gutierrez, S.1    Guillemi, S.2    Jahnke, N.3    Montessori, V.4    Harrigan, P.R.5
  • 12
    • 33846997179 scopus 로고    scopus 로고
    • Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response
    • Jain MK, Comanor L, White C, Kipnis P, Elkin C, et al. (2007) Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response. J Viral Hepat 14: 176-182.
    • (2007) J Viral Hepat , vol.14 , pp. 176-182
    • Jain, M.K.1    Comanor, L.2    White, C.3    Kipnis, P.4    Elkin, C.5
  • 13
    • 84867399642 scopus 로고    scopus 로고
    • Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir+emtricitabine-based HAART in HBV-HIV-coinfected patients
    • Kosi L, Reiberger T, Payer BA, Grabmeier-Pfistershammer K, Strassl R, et al. (2012) Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir+emtricitabine-based HAART in HBV-HIV-coinfected patients. J Viral Hepat 19: 801-10.
    • (2012) J Viral Hepat , vol.19 , pp. 801-810
    • Kosi, L.1    Reiberger, T.2    Payer, B.A.3    Grabmeier-Pfistershammer, K.4    Strassl, R.5
  • 15
    • 69249148630 scopus 로고    scopus 로고
    • Longer duration of HBV-active antiretroviral Therapy is linked to favorable virological outcome in HIV-HBV co-infected patients
    • Lee T, Nunez M, (2009) Longer duration of HBV-active antiretroviral Therapy is linked to favorable virological outcome in HIV-HBV co-infected patients. HIV Clinical Trials 10: 153-159.
    • (2009) HIV Clinical Trials , vol.10 , pp. 153-159
    • Lee, T.1    Nunez, M.2
  • 17
    • 54449097612 scopus 로고    scopus 로고
    • A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand
    • Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, et al. (2008) A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand. Hepatology 48: 1062-1069.
    • (2008) Hepatology , vol.48 , pp. 1062-1069
    • Matthews, G.V.1    Avihingsanon, A.2    Lewin, S.R.3    Amin, J.4    Rerknimitr, R.5
  • 18
    • 69449091614 scopus 로고    scopus 로고
    • A 48-week Study of Tenofovir or Lamivudine or a Combination of Tenofovir and Lamivudine for the Treatment of Chronic Hepatitis B in HIV/HBV-co-infected Individuals
    • Denver, U.S.A
    • Nelson M, Bhagani S, Fisher M, Leen C, Brook G, et al. (2006) A 48-week Study of Tenofovir or Lamivudine or a Combination of Tenofovir and Lamivudine for the Treatment of Chronic Hepatitis B in HIV/HBV-co-infected Individuals. 13th Conference on Retroviruses and Opportunistic Infections. Denver, U.S.A.
    • (2006) 13th Conference on Retroviruses and Opportunistic Infections
    • Nelson, M.1    Bhagani, S.2    Fisher, M.3    Leen, C.4    Brook, G.5
  • 19
    • 37349095628 scopus 로고    scopus 로고
    • Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection
    • Nüesch R, Ananworanich J, Srasuebkul P, Chetchotisakd P, Prasithsirikul W, et al. (2008) Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection. AIDS 22: 152-154.
    • (2008) AIDS , vol.22 , pp. 152-154
    • Nüesch, R.1    Ananworanich, J.2    Srasuebkul, P.3    Chetchotisakd, P.4    Prasithsirikul, W.5
  • 20
    • 33751002371 scopus 로고    scopus 로고
    • Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
    • Peters MG, Andersen J, Lynch P, Liu T, Alston-Smith B, et al. (2006) Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology 44: 1110-1116.
    • (2006) Hepatology , vol.44 , pp. 1110-1116
    • Peters, M.G.1    Andersen, J.2    Lynch, P.3    Liu, T.4    Alston-Smith, B.5
  • 21
    • 47249085228 scopus 로고    scopus 로고
    • Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV
    • Quiros-Roldan E, Calabresi A, Lapadula G, Tirelli V, Costarelli S, et al. (2008) Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV. Antivir Ther 13: 341-348.
    • (2008) Antivir Ther , vol.13 , pp. 341-348
    • Quiros-Roldan, E.1    Calabresi, A.2    Lapadula, G.3    Tirelli, V.4    Costarelli, S.5
  • 22
    • 85056043870 scopus 로고    scopus 로고
    • Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data
    • Rodriguez AE, Dejesus E, Williams V, Irlbeck D, Ross L, et al. (2010) Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data. Open AIDS J 4: 167-170.
    • (2010) Open AIDS J , vol.4 , pp. 167-170
    • Rodriguez, A.E.1    Dejesus, E.2    Williams, V.3    Irlbeck, D.4    Ross, L.5
  • 23
    • 33748894675 scopus 로고    scopus 로고
    • Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
    • Schmutz G, Nelson M, Lutz T, Sheldon J, Bruno R, et al. (2006) Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection. AIDS 20: 1951-1954.
    • (2006) AIDS , vol.20 , pp. 1951-1954
    • Schmutz, G.1    Nelson, M.2    Lutz, T.3    Sheldon, J.4    Bruno, R.5
  • 24
    • 29444435439 scopus 로고    scopus 로고
    • Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus
    • Stephan C, Berger A, Carlebach A, Lutz T, Bickel M, et al. (2005) Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus. J Antimicrob Chemother 56: 1087-1093.
    • (2005) J Antimicrob Chemother , vol.56 , pp. 1087-1093
    • Stephan, C.1    Berger, A.2    Carlebach, A.3    Lutz, T.4    Bickel, M.5
  • 25
    • 67650441920 scopus 로고    scopus 로고
    • Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir
    • Tan LK, Gilleece Y, Mandalia S, Murungi A, Grover D, et al. (2009) Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir. J Viral Hepat 16: 471-478.
    • (2009) J Viral Hepat , vol.16 , pp. 471-478
    • Tan, L.K.1    Gilleece, Y.2    Mandalia, S.3    Murungi, A.4    Grover, D.5
  • 27
    • 10644275213 scopus 로고    scopus 로고
    • Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
    • van Bommel F, Wunsche T, Mauss S, Reinke P, Bergk A, et al. (2004) Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 40: 1421-1425.
    • (2004) Hepatology , vol.40 , pp. 1421-1425
    • van Bommel, F.1    Wunsche, T.2    Mauss, S.3    Reinke, P.4    Bergk, A.5
  • 28
    • 48249122168 scopus 로고    scopus 로고
    • Funnel plots in meta-analysis
    • Sterne J, Harbord R, (2004) Funnel plots in meta-analysis. The Stata Journal 4: 127-141.
    • (2004) The Stata Journal , vol.4 , pp. 127-141
    • Sterne, J.1    Harbord, R.2
  • 29
    • 49949112790 scopus 로고    scopus 로고
    • Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients
    • Lacombe K, Gozlan J, Boyd A, Boelle PY, Bonnard P, et al. (2008) Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients. Antivir Ther 13: 705-713.
    • (2008) Antivir Ther , vol.13 , pp. 705-713
    • Lacombe, K.1    Gozlan, J.2    Boyd, A.3    Boelle, P.Y.4    Bonnard, P.5
  • 30
    • 80052850404 scopus 로고    scopus 로고
    • Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study
    • Si-Ahmed SN, Pradat P, Zoutendijk R, Buti M, Mallet V, et al. (2011) Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study. Antiviral Res 92: 90-95.
    • (2011) Antiviral Res , vol.92 , pp. 90-95
    • Si-Ahmed, S.N.1    Pradat, P.2    Zoutendijk, R.3    Buti, M.4    Mallet, V.5
  • 31
    • 57349095400 scopus 로고    scopus 로고
    • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B
    • Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, et al. (2008) Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med. 359: 2442-2455.
    • (2008) N Engl J Med , vol.359 , pp. 2442-2455
    • Marcellin, P.1    Heathcote, E.J.2    Buti, M.3    Gane, E.4    de Man, R.A.5
  • 32
    • 65449150526 scopus 로고    scopus 로고
    • Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort
    • Alvarez-Uria G, Ratcliffe L, Vilar J, (2009) Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort. HIV Med 10: 269-273.
    • (2009) HIV Med , vol.10 , pp. 269-273
    • Alvarez-Uria, G.1    Ratcliffe, L.2    Vilar, J.3
  • 33
    • 0032760120 scopus 로고    scopus 로고
    • Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
    • Benhamou Y, Bochet M, Thibault V, Di Martino V, Caumes E, et al. (1999) Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology 30: 1302-1306.
    • (1999) Hepatology , vol.30 , pp. 1302-1306
    • Benhamou, Y.1    Bochet, M.2    Thibault, V.3    Di Martino, V.4    Caumes, E.5
  • 34
    • 25444459427 scopus 로고    scopus 로고
    • Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir
    • Sheldon J, Camino N, Rodes B, Bartholomeusz A, Kuiper M, et al. (2005) Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir Ther 10: 727-734.
    • (2005) Antivir Ther , vol.10 , pp. 727-734
    • Sheldon, J.1    Camino, N.2    Rodes, B.3    Bartholomeusz, A.4    Kuiper, M.5
  • 35
    • 34249075512 scopus 로고    scopus 로고
    • In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents
    • Qi X, Xiong S, Yang H, Miller M, Delaney WEt, (2007) In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther 12: 355-362.
    • (2007) Antivir Ther , vol.12 , pp. 355-362
    • Qi, X.1    Xiong, S.2    Yang, H.3    Miller, M.4    Delaney, W.E.5
  • 36
    • 33745630702 scopus 로고    scopus 로고
    • Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus
    • Delaney WEt, Ray AS, Yang H, Qi X, Xiong S, et al. (2006) Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus. Antimicrob Agents Chemother 50: 2471-2477.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 2471-2477
    • Delaney, W.E.1    Ray, A.S.2    Yang, H.3    Qi, X.4    Xiong, S.5
  • 38
    • 65449186952 scopus 로고    scopus 로고
    • The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains
    • Amini-Bavil-Olyaee S, Herbers U, Sheldon J, Luedde T, Trautwein C, et al. (2009) The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains. Hepatology 49: 1158-1165.
    • (2009) Hepatology , vol.49 , pp. 1158-1165
    • Amini-Bavil-Olyaee, S.1    Herbers, U.2    Sheldon, J.3    Luedde, T.4    Trautwein, C.5
  • 39
    • 77957376794 scopus 로고    scopus 로고
    • Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection
    • Berg T, Marcellin P, Zoulim F, Moller B, Trinh H, et al. (2010) Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. Gastroenterology 139: 1207-1217.
    • (2010) Gastroenterology , vol.139 , pp. 1207-1217
    • Berg, T.1    Marcellin, P.2    Zoulim, F.3    Moller, B.4    Trinh, H.5
  • 40
    • 84879998718 scopus 로고    scopus 로고
    • Tenofovir disoproxil fumarate (TDF) versus emtricitabine plus TDF (FTC/TDF) for treatment of chronic hepatitis B (CHB) in patients with persistent viral replication receiving adefovir dipivoxil: final week 168 results
    • Boston, U.S.A
    • Berg T, Marcellin P, Moeller B, Trinh HN, Chan S, et al. (2010) Tenofovir disoproxil fumarate (TDF) versus emtricitabine plus TDF (FTC/TDF) for treatment of chronic hepatitis B (CHB) in patients with persistent viral replication receiving adefovir dipivoxil: final week 168 results. 61st Annual Meeting of the American Association for the Study of Liver Diseases. Boston, U.S.A.
    • (2010) 61st Annual Meeting of the American Association for the Study of Liver Diseases
    • Berg, T.1    Marcellin, P.2    Moeller, B.3    Trinh, H.N.4    Chan, S.5
  • 41
    • 80053199294 scopus 로고    scopus 로고
    • Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir
    • Ong A, Wong VW, Wong GL, Chan HY, Tse CH, et al. (2011) Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir. Aliment Pharmacol Ther 34: 972-981.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 972-981
    • Ong, A.1    Wong, V.W.2    Wong, G.L.3    Chan, H.Y.4    Tse, C.H.5
  • 42
    • 33750937268 scopus 로고    scopus 로고
    • Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen
    • Santos SA, Uriel AJ, Park JS, Lucas J, Carriero D, et al. (2006) Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen. Eur J Gastroenterol Hepatol 18: 1247-1253.
    • (2006) Eur J Gastroenterol Hepatol , vol.18 , pp. 1247-1253
    • Santos, S.A.1    Uriel, A.J.2    Park, J.S.3    Lucas, J.4    Carriero, D.5
  • 43
    • 84856435258 scopus 로고    scopus 로고
    • Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study
    • Petersen J, Ratziu V, Buti M, Janssen HL, Brown A, et al. (2012) Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. J Hepatol 56: 520-526.
    • (2012) J Hepatol , vol.56 , pp. 520-526
    • Petersen, J.1    Ratziu, V.2    Buti, M.3    Janssen, H.L.4    Brown, A.5
  • 44
    • 77949455082 scopus 로고    scopus 로고
    • Predictors of loss of hepatitis B surface antigen in HIV-infected patients
    • Psevdos G Jr, Kim JH, Suh JS, Sharp VL, (2010) Predictors of loss of hepatitis B surface antigen in HIV-infected patients. World J Gastroenterol 16: 1093-1096.
    • (2010) World J Gastroenterol , vol.16 , pp. 1093-1096
    • Psevdos Jr., G.1    Kim, J.H.2    Suh, J.S.3    Sharp, V.L.4
  • 45
    • 78650307553 scopus 로고    scopus 로고
    • Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues
    • Martin-Carbonero L, Teixeira T, Poveda E, Plaza Z, Vispo E, et al. (2010) Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS 25: 73-79.
    • (2010) AIDS , vol.25 , pp. 73-79
    • Martin-Carbonero, L.1    Teixeira, T.2    Poveda, E.3    Plaza, Z.4    Vispo, E.5
  • 46
    • 84865772501 scopus 로고    scopus 로고
    • Hepatitis B Surface Antigen Decline and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV
    • Zoutendijk R, Zaaijer HL, de Vries-Sluijs TE, Reijnders JG, Mulder JW, et al. (2012) Hepatitis B Surface Antigen Decline and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV. J Infect Dis 15: 974-80.
    • (2012) J Infect Dis , vol.15 , pp. 974-980
    • Zoutendijk, R.1    Zaaijer, H.L.2    de Vries-Sluijs, T.E.3    Reijnders, J.G.4    Mulder, J.W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.